Rezaie Alireza R, Yang Likui
Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, 1402 S. Grand Blvd. Saint Louis, MO 63104, USA.
Biophys Chem. 2005 Oct 3;117(3):255-61. doi: 10.1016/j.bpc.2005.06.002.
Thrombomodulin (TM) is as essential cofactor in protein C activation by thrombin. To investigate the cofactor effect of TM on the P3-P3' binding specificity of thrombin, we prepared a Gla-domainless protein C (GDPC) and an antithrombin (AT) mutant in which the P3-P3' residues of both molecules were replaced with the corresponding residues of the factor Xa cleavage site in prethrombin-2. TM is known to interact with GDPC, but not AT in the complex. Thrombin did not react with either mutant in the absence of a cofactor. While the thrombin-TM complex also did not react with the AT mutant, it activated the GDPC mutant with a normal k(cat), but an approximately 4-fold impaired K(m) value. Further studies revealed that the active-site directed inhibitor p-aminobenzamidine acts as a competitive inhibitor of both wild-type and GDPC mutant in reaction with the thrombin-TM complex. These results suggest that the interaction of the P3-P3' residues of GDPC with the active-site pocket of the thrombin-TM complex makes a dominant contribution to the binding specificity of the reaction. Moreover, the observation that the GDPC mutant, but not the AT mutant, functions as an effective substrate for the thrombin-TM complex suggests that GDPC interaction with the thrombin-TM complex may be associated with the alteration of the conformation of the P3-P3' residues of the substrate.
血栓调节蛋白(TM)是凝血酶激活蛋白C过程中必不可少的辅因子。为了研究TM对凝血酶P3 - P3'结合特异性的辅因子作用,我们制备了一种无Gla结构域的蛋白C(GDPC)和一种抗凝血酶(AT)突变体,其中这两种分子的P3 - P3'残基被凝血酶原-2中因子Xa裂解位点的相应残基所取代。已知TM在复合物中与GDPC相互作用,但不与AT相互作用。在没有辅因子的情况下,凝血酶与这两种突变体均不发生反应。虽然凝血酶 - TM复合物也不与AT突变体反应,但它以正常的催化常数(k(cat))激活GDPC突变体,但其米氏常数(K(m))值大约受损4倍。进一步的研究表明,活性位点导向抑制剂对氨基苯甲脒在与凝血酶 - TM复合物反应时,对野生型和GDPC突变体均起竞争性抑制剂的作用。这些结果表明,GDPC的P3 - P3'残基与凝血酶 - TM复合物活性位点口袋的相互作用对反应的结合特异性起主要作用。此外,GDPC突变体而非AT突变体作为凝血酶 - TM复合物有效底物的观察结果表明,GDPC与凝血酶 - TM复合物的相互作用可能与底物P3 - P3'残基构象的改变有关。